
Business Advisor
Accomplished healthcare veteran with special personal interests in a diabetes cure; Board Director at Boston Scientific; Chairman of the Board and CEO of Becton, Dickinson, and Company (BDX); Senior auditor at PWC; Board Director of CVS Health; Board of trustees at Hackensack University Med.; MBA from Columbia University

Clinical Advisor and Collaborator
Recognized medical authority in diabetes; Head of the Diabetes Sect. at the Hospital Universitario Central de Asturias, Oviedo, Spain; Vice Dean at the Uni. of Oviedo School of Med.; VP of the Spanish Society of Endocrinology and Nutrition (SEEN); Corresponding Academician of the Royal Academy of Med. of the Principality of Asturias.

Scientific Advisor and Clinical Partner
20+ year Director of the Cellular Therapy Laboratory at New York Blood Center with specializations in developing stem cell, gene therapy, and immunotherapy products; Associate Member of the Lindsley F. Kimball Research Institute; Head of Myeloproliferative Disorders (MPD) Research Laboratory; PhD and Post-doctoral training from Mount Sinai School of Medicine in New York.

Business Advisor and EU Partner
Director of the Gradus/RSJ Life Sciences Fund; Director of Global Business Development of PrimeCell Therapeutics overseeing the expansion of the largest regenerative medicine company in Central Europe; Analyst and advisor to Amgen, Novartis, Eli Lilly, Allergan, EMD, Serono and Sanofi; MD from the Medical Faculty of Charles University in Prague